MedPath

study of Oxytocin versus Carbetocin for the prevention of primary post partum hemorrhage following caesarean delivery in pregnant wome

Phase 2
Conditions
Health Condition 1: O80-O82- Encounter for delivery
Registration Number
CTRI/2024/04/065815
Lead Sponsor
self
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

female with singleton, fullterm pregnancy undergoing elective or emergency caesarean section,

Exclusion Criteria

Hypersensitivity to study drugs,

Cases of coagulopathy,uterine fibroid,suspected placental pathology,

Medical diseases such as hypertension,diabetes mellitus,Cardiac ,renal,liver disorders .

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Evaluation of hemodynamic effects of carbetocin in terms of blood loss.Timepoint: 24 hours after ceserean section
Secondary Outcome Measures
NameTimeMethod
1.Need of additional uterotonics <br/ ><br>2.Need of blood transfusion to compensate the blood loss. <br/ ><br>3.The adverse effects encountered by the participants.Timepoint: 24 hours after ceserean section
© Copyright 2025. All Rights Reserved by MedPath